https://treelip.com/ 2026-07-02T20:00:17.216Z weekly 1 https://treelip.com/generic-entry-radar/ 2026-07-02T20:00:17.216Z weekly 0.9 https://treelip.com/generic-entry-radar/watchlist/ 2026-07-02T20:00:17.216Z weekly 0.85 https://treelip.com/generic-entry-radar/methodology/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/olux-e/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/alvesco/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zetonna/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/erivedge/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/farydak/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/revlimid/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/finacea/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/sorilux/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/cresemba/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zolinza/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/rytary/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/trokendi-xr/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/koselugo/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zipsor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/verkazia/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/brisdelle/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/qsymia/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/atrovent-hfa/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/acuvue-theravision-with-ketotifen/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/verdeso/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/symbicort-aerosphere/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/apriso/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/namenda-xr/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/amitiza/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/emend/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/entereg/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/gilenya/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/oracea/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zyclara/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/xelpros/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/xalkori/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/tivorbex/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/ninlaro/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zorvolex/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/airsupra/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/mydayis/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/zokinvy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/chlorhexidine-gluconate/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/fabior/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/namzaric/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/embeda/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/ofev/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/vraylar/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/vonjo/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/juxtapid/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/generic-entry-radar/drug/olysio/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/ 2026-07-02T20:00:17.216Z weekly 0.9 https://treelip.com/translational-deal-radar/reports/cell-therapy-deal-radar/ 2026-07-02T20:00:17.216Z weekly 0.85 https://treelip.com/translational-deal-radar/methodology/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/autologous-tumor-infiltrating-lymphocytes/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/tumor-biopsy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/screening-platform/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/dual-target-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/autologous-hematopoietic-stem-cell-transplantation/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/selinexor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dtkn-401-allogeneic-dual-target-cspg4-gd2-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-cd19-car-nk/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/sz003-car-nk/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dt-nk-uc101/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-bcma-car-nk/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dt-car-nk/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-dualnk/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-cd22-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/eb-duo-car-nk-cea-gcc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-mesothelin-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/act-001-car-nk-cell/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/allogenic-cd19-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/bicar-nk-cells-robo1-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/asset/anti-cd33-car-nk-cells/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/translational-deal-radar/institution/inge-marie-svane/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/gustave-roussy-cancer-campus-grand-paris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/glaxosmithkline/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/beijing-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/m-d-anderson-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/second-affiliated-hospital-school-of-medicine-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/shantou-university-medical-college/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/shahid-beheshti-university-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/allife-medical-science-and-technology-co-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/renji-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/xuzhou-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/asclepius-technology-company-group-suzhou-co-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/translational-deal-radar/institution/persongen-biotherapeutics-suzhou-co-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/ 2026-07-02T20:00:17.216Z weekly 0.9 https://treelip.com/tools/adc-target-strategy-radar/oncology/ 2026-07-02T20:00:17.216Z weekly 0.85 https://treelip.com/tools/adc-target-strategy-radar/oncology/methodology/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/her2-erbb2/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/trop2-tacstd2/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/nectin-4-nectin4/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/b7-h3-cd276/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cldn18-2-claudin-18-2/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/fra-folr1-folate-receptor-alpha/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/egfr/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/c-met-met/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/ror1/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/gpc3/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/psma-folh1/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cd30-tnfrsf8/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cd33/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/cd79b/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/bcma-tnfrsf17/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/muc1/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/napi2b-slc34a2/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/dll3/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/liv-1-slc39a6/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/targets/ptk7/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/3h-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/abbvie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/academic-and-community-cancer-research-united/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/adc-therapeutics-s-a/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/adcendo-aps/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/adrienne-g-waks/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/akeso/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/alteogen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/alx-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ambrx/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ana-c-garrido-castro-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/angiex/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/astrazeneca/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/barbara-ann-karmanos-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/beijing-gobroad-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bicycletx-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/biohaven-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/biontech-se/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bolt-biotherapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/bristol-myers-squibb/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/british-columbia-cancer-agency/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/byondis-b-v/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cancer-institute-and-hospital-chinese-academy-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/celgene/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/celldex-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/centre-hospitalier-universitaire-de-saint-etienne/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/charite-university-berlin-germany/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/china-medical-university-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/chong-kun-dang-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/city-of-hope-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/coherent-biopharma-suzhou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/conjupro-biotherapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/corbus-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cspc-megalith-biopharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cspc-zhongqi-pharmaceutical-technology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cstone-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/cullinan-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/daiichi-sankyo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/daiichi-sankyo-taiwan-a-daiichi-sankyo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/dana-farber-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/deepa-jagadeesh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/dualitybio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/eisai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/eisbach-bio-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/elevation-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/eli-lilly-and/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/emd-serono-research-development-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/emory-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/evopoint-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/fondazione-del-piemonte-per-l-oncologia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/fred-hutchinson-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/fudan-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/gbg-forschungs-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/genentech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/genequantum-healthcare-suzhou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/generate-biomedicines/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/genmab/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/george-w-sledge-jr/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/gilead-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/glaxosmithkline/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/groupe-oncologie-radiotherapie-tete-et-cou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/grupo-espanol-de-tumores-neuroendocrinos/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/gustave-roussy-cancer-campus-grand-paris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/hansoh-biomedical-r-d/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/hebei-medical-university-fourth-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/heinrich-elinzano-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/henan-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/hoffmann-la-roche/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/iksuda-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/innolake-biopharm/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/institut-curie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/institut-f-r-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jenny-c-chang-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jiyan-liu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jonsson-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/jules-bordet-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/kivu-bioscience/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/kristina-a-fanucci/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/latin-american-cooperative-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/laura-huppert-md-ba/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/lei-liu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/liaoning-cancer-hospital-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ligachem-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mabwell-shanghai-bioscience/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/macrogenics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/massachusetts-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mayo-clinic/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mbrace-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/medsir/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/memorial-sloan-kettering-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/merck-sharp-dohme/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mersana-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/ming-yuan-chen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mirati-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/multitude-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mustafa-khasraw-mbchb-md-frcp-fracp/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/mythic-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/nader-sanai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/national-cancer-center-japan/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/national-cancer-institute-nci/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/nbe-therapeutics-ag/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/neok-bio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/northwestern-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/nrg-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/obi-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/oncomatryx-biopharma-s-l/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/open-innovation-partners/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-union-medical-college/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-union-medical-college-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/peking-university-cancer-hospital-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/phrontline-biopharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/pierre-fabre-medicament/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/progenics-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/qilu-hospital-of-shandong-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/qilu-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/quantumleap-healthcare-collaborative/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/radboud-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/rayzebio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/regeneron-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/remegen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/renji-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/reshma-l-mahtani-d-o/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/robert-flavell-md-phd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/samsung-bioepis/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/samsung-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sarah-sammons-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/scri-development-innovations/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/seagen-a-wholly-owned-subsidiary-of-pfizer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/second-affiliated-hospital-of-soochow-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/second-affiliated-hospital-school-of-medicine-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/second-xiangya-hospital-of-central-south-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shandong-new-time-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shandong-provincial-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-fosun-pharmaceutical-industrial-development/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-fudan-zhangjiang-bio-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-gynecologic-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-hansoh-biomedical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-henlius-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-junshi-bioscience/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-miracogen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-ninth-people-s-hospital-affiliated-to-shanghai-jiao-tong-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shanghai-zhongshan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sheng-zhang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/shengjing-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sichuan-kelun-biotech-biopharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/solti-breast-cancer-research-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sorrento-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sotio-biotech-a-s/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/st-jude-children-s-research-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/sutro-biopharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/swog-cancer-research-network/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tang-du-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-first-affiliated-hospital-of-soochow-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-first-affiliated-hospital-of-zhengzhou-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-first-affiliated-hospital-with-nanjing-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-methodist-hospital-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/the-netherlands-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/thomas-hope/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tianjin-conjustar-biologics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/unc-lineberger-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/unicancer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-health-network-toronto/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-hospital-caen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-alabama-at-birmingham/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-birmingham/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-california-san-francisco/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-pennsylvania/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/university-of-southampton/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/velavigo-bio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/washington-university-school-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/west-german-study-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/xijing-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/yale-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/yan-xue/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/yonsei-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/zai-lab-shanghai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/zhejiang-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/adc-target-strategy-radar/oncology/sponsors/zymeworks-bc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/protocol-benchmark-radar/ 2026-07-02T20:00:17.216Z weekly 0.9 https://treelip.com/tools/protocol-benchmark-radar/lupus-nephritis/ 2026-07-02T20:00:17.216Z weekly 0.85 https://treelip.com/tools/protocol-benchmark-radar/lupus-nephritis/trials/ 2026-07-02T20:00:17.216Z weekly 0.8 https://treelip.com/tools/protocol-benchmark-radar/lupus-nephritis/methodology/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/ 2026-07-02T20:00:17.216Z weekly 0.9 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/ 2026-07-02T20:00:17.216Z weekly 0.85 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/methodology/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/alk-fusion/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/braf-v600e/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/brca1-2-mutation/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/cldn18-2-expression/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/egfr-exon-19-deletion/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/egfr-l858r/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/egfr-mutation/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/fgfr2-fusion/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/fr-alpha-folr1-expression/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/her2-erbb2-amplification/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/her2-erbb2-expression/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/hrd/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/idh1-mutation/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/kras-g12c/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/kras-g12d/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/met-exon-14-skipping/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/msi-h-dmmr/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/ntrk-fusion/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/pd-l1-expression/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/ret-fusion/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/ros1-fusion/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/biomarkers/tmb-high/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-melanoma-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-nsclc-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-pancreatic-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12c-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/kras-g12d-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-expr-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-colorectal-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-melanoma-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-melanoma-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-pancreatic-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ros1-fusion-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-colorectal-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-colorectal-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-gastric-cancer-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-colorectal-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-melanoma-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-breast-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-breast-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/braf-v600e-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/msi-dmmr-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/alk-fusion-melanoma-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-solid-tumor-basket-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-small-molecule-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/hrd-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-solid-tumor-basket-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/tmb-high-melanoma-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-pancreatic-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fgfr2-fusion-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/idh1-mut-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-pancreatic-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/her2-amp-gastric-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-solid-tumor-basket-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/cldn182-expr-colorectal-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-breast-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-mut-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-ex19-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/egfr-l858r-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/brca12-ovarian-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-pancreatic-cancer-therapy-not-normalized/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-solid-tumor-basket-monoclonal-antibody/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-nsclc-immune-checkpoint-inhibitor/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/pdl1-expr-ovarian-cancer-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ret-fusion-ovarian-cancer-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/met-ex14-ovarian-cancer-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-ovarian-cancer-adc/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/fra-expr-breast-cancer-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/contexts/ntrk-fusion-solid-tumor-basket-combination-therapy/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/23andme,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/3d-medicines-(sichuan)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/7-hills-pharma,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/a&g-pharmaceutical-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/a2-biotherapeutics-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aa-secord/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/abbvie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/abramson-cancer-center-at-penn-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/abscint-nv/sa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/academic-and-community-cancer-research-united/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/academisch-medisch-centrum---universiteit-van-amsterdam-(amc-uva)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/acceleron-pharma,-inc.,-a-wholly-owned-subsidiary-of-merck-&-co.,-inc.,-rahway,-nj-usa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/accent-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/acea-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adagene-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adherex-technologies,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adlai-nortye-biopharma-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/adrienne-g.-waks/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/advaxis,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ago-research-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ahon-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ahs-cancer-control-alberta/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aids-malignancy-consortium/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aio-studien-ggmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aiping-zhou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/akeso/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/albert-einstein-college-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alessandro-santin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alexander-b-olawaiye,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ali-shamseddine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/allegheny-singer-research-institute-(also-known-as-allegheny-health-network-research-institute)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alliance-for-clinical-trials-in-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alliance-foundation-trials,-llc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/allist-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/almac-discovery/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/alphamab-(australia)-co-pty-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ambrx,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/amer-zureikat/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/american-society-of-clinical-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/american-university-of-beirut-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/amgen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aminex-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/amsterdam-umc,-location-vumc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ana-c-garrido-castro,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anbogen-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anchiano-therapeutics-israel-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/andes-biotechnologies/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/andrea-mccart/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anhui-provincial-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anova-innovation-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/anwaar-saeed/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apexigen-america,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apollo-therapeutics-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apollomics-(australia)-pty.-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/apollomics-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aptose-biosciences-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aravive,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arcagy/-gineco-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arcus-biosciences,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arog-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arqule,-inc.,-a-subsidiary-of-merck-sharp-&-dohme-llc,-a-subsidiary-of-merck-&-co.,-inc.-(rahway,-nj-usa)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/array-biopharma,-now-a-wholly-owned-subsidiary-of-pfizer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arrivent-biopharma,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/arvinas-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/asan-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/askgene-pharma,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aslan-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/assistance-publique---hôpitaux-de-paris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/assiut-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astellas-pharma-global-development,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astellas-pharma-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astex-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aston-sci.-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/astrazeneca/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/atreca,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/aveo-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/avistone-biotechnology-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baodong-qin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baohui-han/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/barbara-ann-karmanos-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/barbara-parker,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/base-therapeutics-(shanghai)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/basilea-pharmaceutica/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/basque-health-service/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baxalta-now-part-of-shire/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bayer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baylor-breast-care-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/baylor-college-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bebetter-med-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beigene/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-haidian-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-innocare-pharma-tech-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-mabworks-biotech-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-pearl-biotechnology-limited-liability-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beijing-tide-pharmaceutical-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beni-suef-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/beta-pharma-shanghai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/betta-pharmaceuticals-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bicycletx-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/binhui-biopharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bio-thera-solutions/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biogen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biogenea-pharmaceuticals-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bioinvent-international-ab/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biomedical-radiation-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biomimetix-jv,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bionoxx-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biontech-se/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/biotheus-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bispebjerg-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/black-diamond-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/blokhin's-russian-cancer-research-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/blossomhill-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/blueprint-medicines-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/boehringer-ingelheim/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bolt-biotherapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/brenus-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bridge-biotherapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/bristol-myers-squibb/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/british-columbia-cancer-agency/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/buzzard-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/caicun-zhou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/calico-life-sciences-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cambridge-university-hospitals-nhs-foundation-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/camilla-qvortrup/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/canadian-cancer-trials-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-hospital-chinese-academy-of-medical-science,-shenzhen-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-institute-and-hospital,-chinese-academy-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-research-uk/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cancer-trials-ireland/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/canwell-biotech-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/capital-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/carrick-therapeutics-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/carsgen-therapeutics-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/case-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cdr-life-ag/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cedars-sinai-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/celest-therapeutics-(shanghai)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/celgene/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cellceutix-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/celldex-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-de-recherche-du-centre-hospitalier-universitaire-de-sherbrooke/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-francois-baclesse/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-georges-francois-leclerc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-hospitalier-annecy-genevois/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-hospitalier-de-l'université-de-montréal-(chum)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-hospitalier-universitaire-dijon/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-hospitalier-universitaire-vaudois/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-jean-perrin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-leon-berard/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centre-oscar-lambret/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/centro-de-tratamiento-e-investigación-sobre-cáncer,-luis-carlos-sarmiento-angulo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cha-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chang-gung-memorial-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/changchun-genescience-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/changhai-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/checkpoint-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chen-chunyan/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chengdu-baiyu-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chia-tai-tianqing-pharmaceutical-group-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/children's-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/china-medical-university,-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/china-medical-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-academy-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-lung-cancer-surgical-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-pla-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-society-of-lung-cancer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chinese-university-of-hong-kong/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chipscreen-biosciences,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chongqing-precision-biotech-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chongqing-university-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chonnam-national-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chu-de-quebec-universite-laval/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chugai-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/chungbuk-national-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/city-of-hope-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/clinica-universidad-de-navarra,-universidad-de-navarra/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cliniques-universitaires-saint-luc--université-catholique-de-louvain/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/clovis-oncology,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/coherent-biopharma-(suzhou)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/col-george-peoples,-md,-facs/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/collin-blakely/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/columbia-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/conjupro-biotherapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/consorzio-oncotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/convalife-(shanghai)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/craig-l-slingluff,-jr/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/crimson-biopharm-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cristiana-sessa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cspc-zhongqi-pharmaceutical-technology-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/curis,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cytocom,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/cytomx-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/d3-bio-(wuxi)-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/daiichi-sankyo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/daiichi-sankyo-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dan-zandberg/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dana-farber-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/daping-hospital-and-the-research-institute-of-surgery-of-the-third-military-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dartmouth-hitchcock-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/david-m.-jackman,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/debiopharm-international-sa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/deciphera-pharmaceuticals,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/delmar-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/di-wu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/diwakar-davar/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dizal-(jiangsu)-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dizal-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dompé-farmaceutici-s.p.a/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dong-a-st-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dr-joanne-chiu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/duke-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/dwight-owen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eastern-cooperative-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eastern-hepatobiliary-surgery-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ecog-acrin-cancer-research-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/effector-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/efranat-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eikon-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eisai-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eisai-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eisai-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elevar-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elevation-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eli-avisar,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eli-lilly-and-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elicio-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elizabeth-dudnik/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ella-therapeutics-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ellipses-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elpiscience-biopharma,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/elucida-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/emd-serono-research-&-development-institute,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/emory-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/enb-therapeutics,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/endocyte/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/enterome/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/epiaxis-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/epibiologics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/epicentrx,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/epsilogen-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/eqrx-international,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/erasca,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/erasmus-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/essen-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/etop-ibcsg-partners-foundation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/european-institute-of-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/evelo-biosciences,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/evopoint-biosciences-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/exelixis/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fate-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fatebenefratelli-and-ophthalmic-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/federation-francophone-de-cancerologie-digestive/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fiona-thistlethwaite/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-of-chongqing-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-of-guangxi-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-of-wenzhou-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-of-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-affiliated-hospital-xi'an-jiaotong-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/first-hospital-of-china-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/flame-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/floor-backes,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondation-hôpital-saint-joseph/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondation-ophtalmologique-adolphe-de-rothschild/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-irccs-istituto-nazionale-dei-tumori,-milano/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-per-la-medicina-personalizzata/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-policlinico-universitario-agostino-gemelli-irccs/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fondazione-ricerca-traslazionale/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/foresight-therapeutics-(hefei)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fox-chase-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fred-hutchinson-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/frontier-medicines-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fudan-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fujian-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fujian-medical-university-union-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundacion-clinic-per-a-la-recerca-biomédica/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundación-gecp/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/fundación-pública-andaluza-para-la-gestión-de-la-investigación-en-sevilla/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/galena-biopharma,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/galician-research-group-on-digestive-tumors/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gao-yajie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gbg-forschungs-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gcs-ramsay-santé-pour-l'enseignement-et-la-recherche/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genentech,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/generos-biopharma-hangzhou-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genfleet-therapeutics-(shanghai)-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genmab/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/genprex,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/geoffrey-shapiro,-md,-phd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/georgetown-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gercor---multidisciplinary-oncology-cooperative-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/german-cancer-research-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/german-society-for-pediatric-oncology-and-hematology-gpoh-ggmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gilead-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/glaxosmithkline/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gradalis,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/green-cross-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/groupe-francais-de-pneumo-cancerologie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/groupe-oncologie-radiotherapie-tete-et-cou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/grupo-español-de-investigación-en-cáncer-de-ovario/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gruppo-oncologico-del-nord-ovest/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gruppo-oncologico-italiano-di-ricerca-clinica/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangdong-association-of-clinical-trials/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangdong-provincial-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangzhou-institute-of-respiratory-disease/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guangzhou-xiling-biotechnology-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guiping-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guizhou-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guizhou-provincial-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/guoxin-li/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gustave-roussy,-cancer-campus,-grand-paris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gy-highland-biotech-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/gynecologic-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/h.-kim-lyerly/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/h.-lee-moffitt-cancer-center-and-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haider-mahdi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haihe-biopharma-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haihua-yang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/haining-health-coming-biotech-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hallym-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hamilton-health-sciences-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-acea-pharmaceutical-research-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-converd-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-sumgen-biotech-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hangzhou-zhongmei-huadong-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hanmi-pharmaceutical-company-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/harbin-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/heat-biologics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hebei-medical-university-fourth-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hellenic-cooperative-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hellenic-genitourinary-cancer-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/helsinn-healthcare-sa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/henan-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/henlix,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/herbert-hurwitz/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/herbert-hurwitz,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hibercell,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hideho-okada,-md,-phd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/highfield-biopharmaceuticals-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hoag-memorial-hospital-presbyterian/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hoffmann-la-roche/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/honorhealth-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hospices-civils-de-lyon/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hospital-moinhos-de-vento/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hospital-sirio-libanes/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hotspot-therapeutics,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/huabo-biopharm-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/huashan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hunan-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hunan-province-tumor-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hutchison-medipharma-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hutchmed/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/huyabio-international,-llc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/hôpital-franco-britannique-fondation-cognacq-jay/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/i-mab-biopharma-us-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ibrahim-halil-sahin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/icahn-school-of-medicine-at-mount-sinai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ideaya-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ifom-ets---the-airc-institute-of-molecular-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/iksuda-therapeutics-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/il-yeong-park,-ph.d./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ileukon-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immix-biopharma-australia-pty-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immuneering-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immuneonco-biopharmaceuticals-(shanghai)-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunitybio,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunocore-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunogen,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/immunovaccine-technologies,-inc.-(imv-inc.)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/incyte-biosciences-international-sàrl/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/incyte-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/indaptus-therapeutics,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inhibrx-biosciences,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/innolake-biopharm/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/innovent-biologics-(suzhou)-co.-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inova-health-care-services/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inspirna,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instil-bio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-bergonié/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-claudius-regaud/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-curie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-de-recherches-internationales-servier/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-fuer-frauengesundheit/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-für-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-mutualiste-montsouris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-national-de-la-santé-et-de-la-recherche-médicale,-france/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institut-paoli-calmettes/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institute-of-cancer-research,-united-kingdom/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/institute-of-oncology-ljubljana/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instituto-nacional-de-cancerologia-de-mexico/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/instituto-nacional-de-ciencias-medicas-y-nutricion-salvador-zubiran/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/intensity-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/intergroupe-francophone-de-cancerologie-thoracique/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inventisbio-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/inxmed-(shanghai)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/iovance-biotherapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/iox-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ipsen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ismail-gögenur/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/istituto-romagnolo-per-lo-studio-dei-tumori-dino-amadori-irst-s.r.l.-irccs/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jacobio-pharmaceuticals-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jair-bar,-m.d.,-ph.d./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/james-j-lee/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/janssen-research-&-development,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jean-luc-van-laethem/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jemincare/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jennifer-dorth/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jennifer-lee-caswell-jin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jenny-c.-chang,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jeremy-rudnick,-m.d/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jessica-mezzanotte-sharpe/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-alphamab-biopharmaceuticals-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-aosaikang-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-cancer-institute-&-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-hansoh-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-hengrui-medicine-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-province-nanjing-brain-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangsu-simcere-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiangxi-provincial-people's-hopital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jianming-xu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jinghui-wang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jinming-yu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jiuda-zhao/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/johannes-gutenberg-university-mainz/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/john-grecula/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/john-l.-villano,-md,-phd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/john-waters/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jonsson-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/joseph-sparano/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jules-bordet-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/jun-huang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kadmon-corporation,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kaohsiung-medical-university-chung-ho-memorial-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/karus-therapeutics-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kathy-miller/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kazia-therapeutics-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/keymed-biosciences-co.ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/king-faisal-specialist-hospital-&-research-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/klus-pharma-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/konkuk-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/korea-otsuka-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/korea-university-anam-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/korean-cancer-study-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kristina-a.-fanucci/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kumquat-biosciences-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kunming-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kura-oncology,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kyoto-breast-cancer-research-network/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/kyowa-kirin-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/l-&-l-bio-co.,-ltd.,-ningbo,-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lanova-medicines-development-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lanova-medicines-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lanova-medicines-zhejiang-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/laura-huppert,-md,-ba/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lava-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lee's-pharmaceutical-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/legend-biotech-usa-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/leiden-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/li-zhang,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/liang-wang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/liaoning-cancer-hospital-&-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ligachem-biosciences,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/liuying/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lung-cancer-group-cologne/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lynkcell-europe/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/lyvgen-biopharma-holdings-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/m.d.-anderson-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/m.e.-van-linde/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/maastricht-radiation-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mabwell-(shanghai)-bioscience-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mabxience-research-s.l./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/macrogenics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/manisha-shah/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/marengo-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mario-negri-institute-for-pharmacological-research/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mark-vincent/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/marker-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mary-crowley-medical-research-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/masaryk-memorial-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/masonic-cancer-center,-university-of-minnesota/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/massachusetts-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/matteo's-friends/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/matthew-galsky/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mayo-clinic/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medical-college-of-wisconsin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medical-university-of-silesia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medicallogic/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medicenna-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medimmune-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medolution-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/medsir/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/melanoma-and-skin-cancer-trials-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/melanoma-institute-australia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/memgen,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/memorial-sloan-kettering-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merck-kgaa,-darmstadt,-germany/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merck-sharp-&-dohme-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mereo-biopharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merrimack-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/merus-b.v./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/metanoic-health-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mian-xi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/michael-b.-atkins,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/michael-hopp/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/millennium-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/minghui-zhang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ministry-of-health,-saudi-arabia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mirati-therapeutics-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/molecular-templates,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/moma-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/monte-rosa-therapeutics,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/montefiore-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mothaffar-rimawi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/mridula-george,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/multitude-therapeutics-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/multivir,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/myung-ju-ahn/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanfang-hospital,-southern-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanjing-first-hospital,-nanjing-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nanobiotix/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nantbioscience,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nantes-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nantpharma,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-center,-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-center,-japan/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-center,-korea/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-center-hospital-east/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-centre,-singapore/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-institute,-naples/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-cancer-institute-(nci)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-guard-health-affairs/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-institute-of-health-research-and-development,-ministry-of-health-republic-of-indonesia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-taiwan-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/national-university-hospital,-singapore/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nationwide-children's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/navire-pharma-inc.,-a-bridgebio-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nec-bio-b.v/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nec-oncoimmunity-as/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/neelesh-sharma-md-phd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nektar-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/neonc-technologies,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/neotx-therapeutics-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nerviano-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/new-beta-innovation-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/newlink-genetics-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nextcure,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/niels-junker/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nimbus-wadjet,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ningbo-junyan-hongshi-biosciences-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nir-peled/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nisha-mohindra,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/northwell-health/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/northwestern-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nouscom-srl/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/novartis-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/novocure-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nrg-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nsabp-foundation-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nucana-plc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nuvation-bio-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nykode-therapeutics-asa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/nyu-langone-health/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/obstetrics-&-gynecology-hospital-of-fudan-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/odense-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/odonate-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ohio-state-university-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ohsu-knight-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/olivia-newton-john-cancer-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/omico/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/on-target-laboratories,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncoethix-gmbh,-a-subsidiary-of-merck-&-co.,-inc.-(rahway,-new-jersey-usa)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncolytics-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncomatryx-biopharma-s.l./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncomed-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oncxerna-theraputics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ono-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oryx-gmbh-&-co.-kg/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oslo-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ospedale-san-carlo-borromeo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ottawa-hospital-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/oxford-university-hospitals-nhs-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/p.o.-witteveen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/parabilis-medicines,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pediatric-brain-tumor-consortium/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-union-medical-college/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-union-medical-college-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-cancer-hospital-&-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-first-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-shenzhen-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/peking-university-third-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pfizer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/phanes-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharmaand-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharmacyclics-llc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharmaengine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pharmicell-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/piramal-enterprises-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pliant-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/presage-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/priscilla-mcauliffe/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/puma-biotechnology,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/pure-biologics-s.a./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qianfoshan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qilu-hospital-of-shandong-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qilu-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qingdao-central-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/quantumleap-healthcare-collaborative/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/queen-mary-university-of-london/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/queensland-centre-for-gynaecological-cancer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/qurebio-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/r-pharm/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/radboud-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/radiopharm-theranostics,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/redcloud-bio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/regeneron-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/relay-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/remegen-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/renji-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rennes-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/renske-altena/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/replimune,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/revolution-medicines,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rigshospitalet,-denmark/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rita-sanghvi,-mehta/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/roger-williams-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/roswell-park-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/royal-cornwall-hospitals-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/royal-marsden-nhs-foundation-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/ruijin-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/rutgers,-the-state-university-of-new-jersey/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sameek-roychowdhury/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/samsung-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sandoz/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sanofi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sarah-sammons,-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sarah-weiss/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sarcoma-oncology-research-center,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/scri-development-innovations,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sds-optic-s.a./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seagen,-a-wholly-owned-subsidiary-of-pfizer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seagen-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-affiliated-hospital,-school-of-medicine,-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-affiliated-hospital-of-guangzhou-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-affiliated-hospital-of-nanchang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-military-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/second-xiangya-hospital-of-central-south-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/seoul-national-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/servier-bio-innovation-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-cancer-hospital-and-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-new-time-pharmaceutical-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-provincial-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-suncadia-medicine-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shandong-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-allink-biotherapeutics-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-cancer-hospital,-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-cell-therapy-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-chest-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-chia-tai-tianqing-pharmaceutical-technology-development-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-children's-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-general-hospital,-shanghai-jiao-tong-university-school-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-hengrui-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-henlius-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-huaota-biopharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-jmt-bio-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-junshi-bioscience-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-kanda-biotechnology-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-longyao-biotechnology-inc.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-miracogen-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-public-health-clinical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-pulmonary-hospital,-shanghai,-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-qilu-pharmaceutical-research-and-development-center-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-yingli-pharmaceutical-co.-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanghai-zhongshan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shanxi-province-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shattuck-labs,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sheba-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sheng-zhang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shenzhen-fifth-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shenzhen-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shenzhen-university-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shi-yuankai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shijiazhuang-yiling-pharmaceutical-co.-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shionogi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/shouyao-holdings-(beijing)-co.-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-baili-pharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-cancer-hospital-and-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-huiyu-pharmaceutical-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-kelun-biotech-biopharmaceutical-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sichuan-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sierra-oncology-llc---a-gsk-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sihuan-pharmaceutical-holdings-group-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/simcha-il-18,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sir-run-run-shaw-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sixth-affiliated-hospital,-sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/smartnuclide-biopharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/solti-breast-cancer-research-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/soroka-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sotio-biotech-a.s./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sotio-biotech-ag/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/spanish-breast-cancer-research-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/spanish-cooperative-group-for-the-treatment-of-digestive-tumours-(ttd)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/spanish-lung-cancer-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sparx-biotech(jiangsu)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/spectrum-pharmaceuticals,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/st-vincent's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/stanford-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/strata-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sumitomo-pharma-america,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sun-pharma-advanced-research-company-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sung-yong-lee/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sunnybrook-health-sciences-centre/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sunshine-lake-pharma-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/susan-e.-bates/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/susanne-crocamo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/sutro-biopharma,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-genhouse-bio-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-immunofoco-biotechnology-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-junjing-biosciences-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-puhe-pharmaceutical-technology-co.,-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-suncadia-biopharmaceuticals-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-transcenta-therapeutics-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/suzhou-zelgen-biopharmaceuticals-co.,ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/swiss-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/swog-cancer-research-network/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/syndax-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tachyon-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tae-won-kim/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taiho-oncology,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taipei-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taipei-veterans-general-hospital,-taiwan/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taizhou-eoc-pharma-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taizhou-hanzhong-biomedical-co.-ltd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/taizhou-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/takeda/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tang-du-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tanta-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tata-memorial-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/technical-university-of-munich/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tehran-university-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tel-aviv-sourasky-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/teligene-us/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tesaro,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-affiliated-hospital-of-qingdao-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-belgian-society-of-medical-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-guangzhou-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-soochow-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-xiamen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-of-zhengzhou-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-first-affiliated-hospital-with-nanjing-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-greater-poland-cancer-centre/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-hospital-for-sick-children/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-methodist-hospital-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/the-netherlands-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/theodoros-foukakis/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/theras,-inc.,-d/b/a-bbot-(bridgebio-oncology-therapeutics)/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/third-affiliated-hospital,-sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/thomas-jefferson-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tian-xie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tianjin-medical-university-second-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/timothy-burns,-md,-phd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tj-biopharma-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tolremo-therapeutics-ag/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tomsk-national-research-medical-center-of-the-russian-academy-of-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tongji-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tongji-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/topalliance-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tragara-pharmaceuticals,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/translational-genomics-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/translational-oncology-research-international/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/transthera-sciences-(nanjing),-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/traws-pharma,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/treos-bio-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/triana-biomedicines,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/triumvira-immunologics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tty-biopharm/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/turning-point-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tvardi-therapeutics,-incorporated/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/tyk-medicines,-inc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/udai-kammula/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/unc-lineberger-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/unicancer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/union-hospital,-tongji-medical-college,-huazhong-university-of-science-and-technology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/universidad-europea-de-madrid/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/universitair-ziekenhuis-brussel/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/universitaire-ziekenhuizen-ku-leuven/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-college,-london/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-health-network,-toronto/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-bordeaux/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-brest/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-clermont-ferrand/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital,-essen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital-heidelberg/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-hospital-hradec-kralove/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-medical-center-goettingen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-medical-center-groningen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-alabama-at-birmingham/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-arizona/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-arkansas/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-davis/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-irvine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-san-diego/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-california,-san-francisco/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-campania-luigi-vanvitelli/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-chicago/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-colorado,-denver/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-florida/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-iowa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-kansas-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-lausanne-hospitals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-leicester/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-magdeburg/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-maryland,-baltimore/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-massachusetts,-worcester/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-michigan-rogel-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-nebraska/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-oklahoma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-pennsylvania/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-pittsburgh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-southern-california/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-texas-southwestern-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-utah/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-vermont-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-virginia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-warmia-and-mazury/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-washington/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-wisconsin,-madison/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/university-of-zurich/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/universität-duisburg-essen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/us-oncology-research/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/va-office-of-research-and-development/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vaccinex-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/val-adams/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vall-d'hebron-institute-of-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vanderbilt-ingram-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vejle-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/verastem,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vincerx-pharma,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/virginia-commonwealth-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vitrac-therapeutics,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vividion-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vm-oncology,-llc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/vyriad,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wake-forest-university-health-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/washington-university-school-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wayshine-biopharm,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wei-xu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/weijing-sun,-md,-facp/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/weill-medical-college-of-cornell-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wellmarker-bio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/werewolf-therapeutics,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/west-china-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/west-virginia-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wigen-biomedicine-technology-(shanghai)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/william-bradley/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wntresearch-ab/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/woman's/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/women's-hospital-school-of-medicine-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/worldwide-innovative-network-association/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/wuxi-no.-4-people's-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xencor,-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xi-junjie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xiangbo-wan/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xiangdong-cheng/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xiangya-hospital-of-central-south-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xijing-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xin-hua-xu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xinhua-hospital,-shanghai-jiao-tong-university-school-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xinjiang-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xinqiao-hospital-of-chongqing/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/xu-jianmin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/y-biologics-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yale-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yan-xue/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yonsei-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yu-jiren/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/yugui-lian/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zai-biopharmaceutical-(suzhou)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zai-lab-(shanghai)-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zealand-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-doer-biologics-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-medicine-co.,-ltd./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhi-yang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhigang-li/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhiyong-yu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhonglin-hao/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zhongnan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zuoyi-jiao/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/biomarker-patient-selection-radar/solid-tumor-oncology/sponsors/zymeworks-bc-inc./ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/ 2026-07-02T20:00:17.216Z weekly 0.9 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/ 2026-07-02T20:00:17.216Z weekly 0.85 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/methodology/ 2026-07-02T20:00:17.216Z monthly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/1-mg-kg-iv-fl-301/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/177lu-ludotadipep-3-7-gbq/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/17b-estradiol/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/18f-fluorofuranylnorprogesterone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/18f-fluoromisonidazole/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/3cycles-toripalimab-cetuximab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/5-fluorouracil/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/6-0-mg-kg-of-tqb2102-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/68ga-psma/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/7mw3711-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/7mw4911/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/9mw2821/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/9mw2821-other-anticancer-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/a1-shr-a1811/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/a166/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/abemaciclib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/acalabrutinib-tacrolimus-methotrexate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/acelarin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/acetylsalicylic-acid/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ad-rts-hil-12/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adagrasib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adaptive-radiotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adavosertib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adct-602/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adebrelimab-gemox-tki/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adg106/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adh-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adi-peg-20/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/adjuvant-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/afatinib-bibw-2992/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/akt-inhibitor-gsk2141795/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/al2846/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/aldesleukin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/aldoxorubicin-hcl/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/alectinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/alisertib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/all-trans-retinoic-acid/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/allogeneic-bk-specific-cytotoxic-t-lymphocytes/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/allogeneic-hematopoietic-stem-cell-transplantation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/almonertinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amg-479/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amivantamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amt-116/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/amuvatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anamorelin-hcl/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anastrozole/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/androgen-deprivation-therapy-adt/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anetumab-ravtansine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-hydrochloride-etoposide-and-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-nab-paclitaxel-carboplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anlotinib-plus-toripalimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-bcma-gprc5d-car-t-cell/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-cd123-adc-imgn632/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-cd19-22-car-vector-transduced-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-endoglin-chimeric-monoclonal-antibody-trc105/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anti-pd-1-monoclonal-antibody/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/antibody-drug-conjugate-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/antineoplaston-therapy-atengenal-astugenal/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/anv419/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/apatinib-monotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arm-1-dc-vaccine-rt/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arsenic-trioxide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/artesunate-200mg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/arx788/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/asn-002/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/asp3082/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/asp546c/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/asparaginase-erwinia-chrysanthemi/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atezolizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atn-224/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/atorvastatin-calcium/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-anti-mart-1-f5-t-cell-receptor-gene-engineered-peripheral-blood-lymphocytes/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cell-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cell-vaccine-dc-pc3/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-co-cultured-with-cytokine-induced-killer-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-dc-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-electroporated-with-mrna/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-dendritic-cells-loaded-with-mage-a3-melana-and-survivin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-hematopoietic-stem-cell-transplantation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/autologous-tumor-lysate-pulsed-dc-vaccination/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/auy922/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/av-gbm-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/avelumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/axatilimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azacitidine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd0305/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd0516/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd0901/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd2265-fpi-2265/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/azd8853/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/b10-l-bpa-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ba3071/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bat8006-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/batiraxcept/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bay73-4506-regorafenib-stivarga/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bb-1701/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/becotatug-vedotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/becotatug-vedotin-and-pucotenlimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/belantamab-mafodotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/belinostat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bendamustine-hydrochloride/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/benmelstobart/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/berzosertib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/best-practice/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bevacizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bevacizumab-and-erlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bevacizumab-avastin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bexarotene/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bhb810/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bi-505/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bi-836826/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bibf-1120/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bintrafusp-alfa-m7824/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bio-106/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biopsy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biopsy-procedure/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/biospecimen-collection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bl-8040/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bl-b01d1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bleomycin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bms-986183/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bn83495/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bnt327-dose-level-1-dl1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bortezomib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/botensilimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/brazikumab-iv-infusion/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/breath-sample-collection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/brentuximab-vedotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/bryostatin-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/budesonide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/busulfan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cab-axl-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cab-ror2-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cabozantinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cadonilimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/calcium/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/calcium-electroporation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/camrelizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/camrelizumab-albumin-bound-paclitaxel-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/capecitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/car-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carboplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carboplatin-auc-10/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/carfilzomib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cc-486/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/celecoxib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cell-therapy-product/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cemiplimab-monotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cend-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cetuximab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cetuximab-paclitaxel-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cevostamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chemotherapy-disulfiram/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chemotherapy-followed-dendritic-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chemotherapy-plus-dual-target-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chloroquine-standard-dose-500mg-week/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/choline-magnesium-trisalicylate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chop-selinexor-5-azacitidine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/chronic-myeloid-leukemia-nk-cell/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cilengitide-2-times-weekly/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ckd-703/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cladribine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/clinimacs-cell-separation-system/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cobimetinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cobolimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/coformulated-favezelimab-pembrolizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cognitive-assessment/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cohort-1-her2-positive-rc48-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/combination-nivolumab-and-ipilimumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/combination-of-fruquintinib-and-camrelizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/combination-of-relatlimab-and-nivolumab-wich-are-two-immunotherapy-treatments/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/combined-adenovirus-vectored-p53-tranfected-dedritic-cell-vaccine-and-ex-vivo-expanded-t-lymphocytes/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/computed-tomography/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/computed-tomography-ct/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/copanlisib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cp-675-206/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/crizotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/crlx101/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cromolyn-tqb2102-and-panpulimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cryoablation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cryosurgery/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cvac/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cxcr1-2-inhibitor-sx-682/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cyclophosphamide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cyclophosphamide-topotecan-and-bevacizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/cytarabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dabrafenib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dabrafenib-150-mg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dacomitinib-pf-00299804/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dalpiciclib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dalpiciclib-125mg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dalteparin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/daratumumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/daratumumab-thalidomide-and-dexamethasone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dartregs/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dasatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/datopotamab-deruxtecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/datopotamab-deruxtecan-dato-dxd/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/db-1311-bnt324/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dc-tn-muc1-autologous-dendritic-cells-expressing-tn-muc1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dc-vaccine-and-cyclophosphamide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/decitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/decitabine-and-genistein/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/decoy20/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/deferasirox/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/defined-green-tea-catechin-extract/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dendritic-cell-vaccination/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dendritic-cells-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/diffusion-weighted-imaging/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin-anlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/disitamab-vedotin-rc48-plus-tratuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dmf5-melanoma-reactive-til/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/docetaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/docetaxel-cisplatin-and-5-fluorouracil/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dose-escalation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/dostarlimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/doxorubicin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/doxorubicin-hydrochloride/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/doxycycline/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/drepaglobe-drug-product/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ds-1062a/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ds-8201a/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/duloxetine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/durvalumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/durvalumab-with-carboplatin-paclitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ebc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ebnk-1822h2-dual-target-cldn18-2-her2-car-nk-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/efprezimod-alfa-human-cd24-extracellular-domain-and-human-igg1-fc-fusion-protein/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eis-12656/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eltrombopag/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/emibetuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/encorafenib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/endostar/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/endotoxin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enfortumab-vedotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eni-using-imrt-with-or-without-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enobosarm/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/entinostat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/entrectinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/env-501/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enzalutamide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/enzastaurin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ep-ec-pd-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/epcoritamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eribulin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/eribulin-mesylate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/erlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/erlotinib-and-capecitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/erlotinib-hydrochloride/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/es014/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/es101/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/estramustine-phosphate-sodium/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/etanercept/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/etoposide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/etoposide-capsules/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/etoposide-doxorubicin-cisplatin-and-mitotane-plus-megestrol-acetate-160-mg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/everolimus/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/evinacumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/extended-dose-interval-immunotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/extracorporeal-photopheresis/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/falimarev/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/farletuzumab-ecteribulin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ferumoxytol/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fezolinetant/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ff-10502-01/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fianlimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/filgrastim/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/filgrastim-75mcg-0-3ml/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fixed-dose-combination-of-pertuzumab-and-trastuzumab-as-subcutaneousformulation-q3w-and-nab-paclitaxel-in-3-week-cycle-for-total-6-cycles-with-inavolisib-6-cycles-or-without-inavolisib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/flotetuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fludarabine-phosphate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/flumatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fluorouracil/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fluorouracil-5-fu/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/flx475/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fmiso/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/folfirinox/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fosciclopirox/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fractionated-dose-of-225ac-j591/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fruquintinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/fwd1802/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gamma-secretase-inhibitor-pf-03084014/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ganetespib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gefitinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gefitinib-irinotecan-cycophosphamide-doxorubicin-etoposide-cisplatin-topotecan-carboplatin-melphalan-13-cis-retinoic-acid/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine-and-cisplatin-dd-gc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine-hydrochloride/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gemcitabine-oxaliplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gen1053/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ges-gemcitabine-erlotinib-s-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gfs101a/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/giredestrant/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gliadel-wafers-in-combination-with-o6-benzylguanine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/glofitamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/golidocitinib-plus-chop/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/goserelin-acetate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gp100-antigen/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/granisetron-transdermal-delivery-system/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gs-toripalimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gsk1120212/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gsk1363089-foretinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/gsk5764227/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ha121-28-tablets/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/haic/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hemospan-mp4ox/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hepatic-arterial-infusion-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/her-2-neu-peptide-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/her2bi-armed-activated-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/high-dose-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hiltonol-and-autologous-dendritic-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hla-g-car-bite-allogeneic-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43-dose-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx43-dose-1-2-5-mg-kg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx87-hlx22/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hlx87-hx22/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hp-211/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hp518-dose-escalation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hs-10296-almonertinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hs-20089/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hs-20093/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hs-20105/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/htert-mrna-dc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/humanized-anti-pd-1-monoclonal-antibody-toripalimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hx008/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hybrid-palliative-radiation-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hydroxychloroquine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hyperbaric-oxygen-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hypofractionated-radiation-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/hypofractionated-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/i-dxd/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iah0968/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iap0971/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ibi129/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ibrutinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/icasp9m28z-t-cell-infusions/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/idarubincin-and-amufostine-ethyol/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ide196/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ifinatamab-deruxtecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/il-2-and-nivolumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ilb-2109/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imatinib-mesylate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/imx-110/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/in10018/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/incmga00012-pd-1-antibody/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/indium-in-111-ll2-igg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/inetetamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/inotuzumab-ozogamicin-io/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/intensity-modulated-radiation-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/interferon-gamma-1b/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/intermittent-hypoxic-training-iht/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/investigator-choice-re-challenge-with-anti-egfr-rx/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iodine-i-125/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iodine-i-131-monoclonal-antibody-bc8/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ionis-stat3rx/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iparomlimab-and-tuvonralimab-injection-in-combination-with-lenvatinib-or-axitinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iparomlimab-and-tuvonralimab-ql1706-combined-with-platinum-based-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ipilimumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ipn60300/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/irinotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/irofulven/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/isatuximab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/isis-2503/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/itacitinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/itraconazole/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iv-ict01/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ivonescimab-combined-with-trop2-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ixabepilone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/iza-bren/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/jcar015-cd19-targeted-car-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/jmt203-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/jnj-64041757/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/js001/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/js212-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/kd6001/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/kds2010/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/khn922-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/klh-pulsed-autologous-dendritic-cell-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ky-0301/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/l-dos47/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/laboratory-biomarker-analysis/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lamivudine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/laparotomy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lapatinib-1-23-mg-eribulin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lapatinib-ditosylate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/laser-interstitial-thermal-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lazertinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lcb02a/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lcb84/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lee011-ribociclib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenalidomide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenalidomide-10-mg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenalidomide-plus-melphalan-during-autologous-stem-cell-transplantation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lenvatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/letrozole/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/letrozolo-cyclophosphamide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/leucovorin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/liposomal-irinotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lm-302-candonilimab-capecitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lns8801-small-molecule-orally-bioavailable-selective-agonist-of-gper/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lomvastomig/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/loncastuximab-tesirine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/loncastuximab-tesirine-150-g-kg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/losartan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/loxl2-inhibitor-pat-1251/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/lsta1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ly2157299/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ly2439821/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ly2875358/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/m200-volociximab-in-combination-with-dacarbazine-dtic/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/m7824/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/m9140/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/macrogol-3350-based-oral-osmotic-laxative/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/magnetic-resonance-imaging/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mart-1-antigen/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mdv9300/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mesenchymal-progenitor-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mesopher/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mesothelin-and-claudin-18-2-car-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mfolfirinox/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mfolfox6-folinic-acid-5-fluorouracil-and-oxaliplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mhb036c-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mhb048c-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mhb088c-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirdametinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirvetuximab-soravtansine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirvetuximab-soravtansine-gynx/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mirvetuximab-soravtansine-mirv-imgn853/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mitoxantrone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-1200/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-2206/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-3120/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mk-3475/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mocetinostat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/molecularly-tailored-second-line-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/morab-202/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg002/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg002-hx008/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003-and-toripalimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003-combined-with-dalpicicilip/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg003-hx008/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg004a/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrg006a/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mrna-4157/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mtx-463/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/mycophenolate-mofetil-plus-prednisone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/n-acetyl-l-cysteine-dietary-supplement/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nab-paclitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/naloxegol/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nanoliposomal-irinotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/navicixizumab-paclitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nbm-bmx-capsule-are-proprietary-products-developed-by-novelwise-pharmaceutical-corporation-novelwise-for-treatment-of-patients-suffering-from-cancers/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nc318/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/necitumumab-gemcitabine-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/necvax-neo1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/neoadjuvant-capecitabine-panitumumab-and-radiation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/neoadjuvant-treatment-mfolfox6-pembrolizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/neratinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nimesulide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nintedanib-or-placebo-carboplatin-paclitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/niraparib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab-injectable-product/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nivolumab-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nt-i7/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/nx-5948/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ny-eso-1-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/obatoclax-mesylate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/obi-999/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/odm-212/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/olaparib-177lu-dotatate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/olaratumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/one-three-cycles-of-cell-therapy-during-4-6-weeks-3-5x10-7-cells-kg-will-be-given-through-iv-systemically/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/onm-100/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ono-4578/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/onvansertib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/opaganib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/open-label-selinexor/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/orteronel-prednisone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/osi-211-liposomal-lurtotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/osimertinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/osimertinib-80-mg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/osimertinib-sacituzumab-tirumotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/otx-2002/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/oxaliplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/p276-00/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paclitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paclitaxel-albumin-nanoparticle-for-injectable-suspension/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/paclitaxel-polymer-micelles-gemcitabine-lenvatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/palbociclib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/panitumumab-paclitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/patritumab-deruxtecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pd-1-antibody/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/peg-interferon-alfa-2b/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/peginterferon-alpha-2b-pegifna2b/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pegylated-recombinant-human-hyaluronidase-ph20/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pembrolizumab-pemetrexed-platinum/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pemetrexed/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pemigatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pentamidine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pep-dc1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pepinemab-pembrolizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/personalized-dendritic-cell-vaccine-zsneo-dc1-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pertuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pevonedistat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pf-00299804/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pik3ca-inhibitor/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/plamotamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pm01183/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pm8002/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pomalidomide-and-dexamethasone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/poziotinib-once-daily-dosing/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pr1-leukemia-peptide-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pracinostat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/prednisone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/prl3-zumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/probiotic/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/prostate-biopsy-focal-brachytherapy-assessment-of-qol/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/prostvac-v-f/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ps-341-doxorubicin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/psma-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pucotenlimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pumitamig/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pxd101with-cisplatin-doxorubicin-cyclophosphamide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/pyrotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ql1706/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ql1706-bispecific-antibody-targeting-pd-1-and-clta-4/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qlc5513/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qls5132-bevacizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/qls5133/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/quad-shot/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/quadrivalent-hpv-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/quemliclustat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/r-dxd/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rad001/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiation-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiotherapy-low-risk-group/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radiotherapy-rituximab-and-dc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radium-223-dichloride/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/radium-223-dichloride-xofigo-bay88-8223/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/raludotatug-deruxtecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/raludotatug-deruxtecan-r-dxd/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ramucirumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rapa-201-rapamycin-resistant-t-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc108/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc118/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc-2-5mg-kg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc-combined-with-toripalimab-for-bladder-sparing-therapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc48-adc-in-combination-with-gemcitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rc88/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rcomp/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-interferon-alfa-2b/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/recombinant-interferon-gamma/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/reduced-intensity-conditioning/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/regn5668/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/regorafenib-stivarga-bay73-4506/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rem-422/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/reolysin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rituximab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rituximab-methylprednisolone/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rosiglitazone-maleate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/rptr-1-201/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ruxolitinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/s1-plus-docetaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sac-tmt/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-govitecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-govitecan-hziy-sg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-govitecan-sg/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-and-anlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-and-limertinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sacituzumab-tirumotecan-plus-tagitanlimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sagopilone-16-mg-m-2-i-v-acetyl-l-carnitine-alc-1000-mg-tid-hrpc-only-prednisone-or-prednisolone-5-mg-bid/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/salvage-sbrt/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/saracatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sargramostim/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sargramostim-leukine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sb012/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sbrt-lattice-pathy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sd-101-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/selinexor/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/selpercatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/serplulimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sgt-53/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-1210/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-4602/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1811/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1811-adebrelimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1811-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a1921-injection-and-adebrelimab-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/shr-a2102-or-and-hrs-4642/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/simtuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/simvastatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/single-arm-open-label/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sintilimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sintilimab-combined-with-anlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sintilimab-combined-with-apatinib-and-capecitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sintilimab-pegaspargase/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sirolimus/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sitravatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/skb103-for-injection-monotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/skb264/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/skb500-powder-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/skb571-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/smp3124lp/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/soc-plus-trastuzumab-and-pembrolizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sorafenib-tosylate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/spartalizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sra737-gemcitabine-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/standard-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/standard-radiotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/stereotactic-body-radiation-therapy-sbrt/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/stereotactic-body-radiation-treatment-sbrt/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/stereotactic-body-radiotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/stereotactic-radiosurgery/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sti-6129/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sunitinib-malate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sunvozertinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sunvozertinib-in-combination-with-anlotinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/suramin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/surgery/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/surufatinib-in-combination-with-gemcitabine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/sys6090-pemetrexed-platinum-based-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tac01-her2/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tak-788/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/talquetamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tamoxifen-citrate/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tanespimycin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tapcells-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tarceva/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tazemetostat/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/telotristat-ethyl/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/temozolomide/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/temozolomide-and-radiotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tesetaxel-capecitabine-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tesevatinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/th-302/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/therapeutic-allogeneic-lymphocytes/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/therapeutic-autologous-dendritic-cells/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/therapeutic-conventional-surgery/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/therapeutic-intervention/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tislelizumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tislelizumab-combined-with-neoadjuvant-radiotherapy-and-chemotherapy/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tisotumab-vedotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tivozanib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tj1133-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tki258/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tocilizumab-20-mg-ml-intravenous-solution/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tomox-haic/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/topical-tretinoin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/topotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/toripalimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/toripalimab-plus-nab-paclitaxel-cisplatin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/torvutatug-samrotecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/total-body-irradiation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/total-body-irradiation-tbi-plan-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb2102-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb2450-anlotinib-docetaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb2825-injection-gemcitabine-hydrochloride-for-injection-oxaliplatin-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tqb6411-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trans-resveratrol/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-deruxtecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-emtansine-kadcyla/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-herceptin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-rezetecan/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/trastuzumab-rezetecan-for-injection-shr-a1811/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/treatment/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tricar-t-cd19/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tub-030/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tub-040/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tumor-infiltrating-lymphocytes-til/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tumor-lysate-pulsed-autologous-dendritic-cell-vaccine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tunlametinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tunlametinib-pd-1-mab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/tvgv-1/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ty-9591-tablets/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/u3-1402/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ubamatamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ublituximab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/ultratrace-iobenguane-i131/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/unconjugated-belantamab-antibody/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/upifitamab-rilsodotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/urelumab-nivolumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/valproate-plus-doxorubicin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vdc2008/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vebrekotuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/velcade/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vemurafenib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vib305-for-injection/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vibecototamab-iv-putilimab-iv/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vidutolimod-cmp-001/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vismodegib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vobramitamab-duocarmazine/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/volonib-combined-with-everolimus-formation/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/vudalimab-carboplatin-cabazitaxel/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/wjb001/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/xav-19/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/xentuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/xofigo/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/yl-13027/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/yl242/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zalypsis-pm00104/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zanidatamab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zanzalintinib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zd6474-vandetanib/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zenocutuzumab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zg005/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zilovertamab-vedotin/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zimberelimab/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/assets/zo-nantax/ 2026-07-02T20:00:17.216Z weekly 0.6 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/adcendo-aps/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/adherex-technologies/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/agenus/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ahs-cancer-control-alberta/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aids-malignancy-consortium/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aivita-biomedical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/alaunos-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/alliance-for-clinical-trials-in-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ambrx/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/amphera-bv/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/anaveon-ag/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/annick-desjardins/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/anup-kasi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/aravive/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/arcagy-gineco-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/armando-santoro-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ascend-biopharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/assistance-publique-h-pitaux-de-paris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/assiut-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/association-pour-la-recherche-des-th-rapeutiques-innovantes-en-canc-rologie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astellas-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astellas-pharma-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astellas-pharma-global-development/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astex-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/astrazeneca/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/attaya-suvannasankha/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/attenuon/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/australasian-gastro-intestinal-trials-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/azienda-socio-sanitaria-territoriale-degli-spedali-civili-di-brescia/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/barbara-ann-karmanos-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/barts-the-london-nhs-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bayer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/baylor-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beijing-biohealthcare-biotechnology-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/beijing-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bighat-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bio-thera-solutions/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bioatla/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bioinvent-international-ab/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bionecure-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/biontech-se/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/biotheus/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/boehringer-ingelheim/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bostwick-laboratories/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/bristol-myers-squibb/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/brown-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/burzynski-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/california-cancer-consortium/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/canadian-cancer-trials-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cancer-institute-and-hospital-chinese-academy-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cancer-research-uk/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cardiff-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/carolina-research-professionals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/case-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/celgene/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-hospitalier-universitaire-de-saint-etienne/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-hospitalier-universitaire-vaudois/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/centre-leon-berard/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chang-gung-memorial-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chengdu-kanghong-biotech-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chenxu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chia-tai-tianqing-pharmaceutical-group-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/children-s-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/china-medical-university-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/china-medical-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chinese-academy-of-medical-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chinese-pla-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chinese-university-of-hong-kong/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chong-kun-dang-pharmaceutical/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/chongqing-university-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ciclomed/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/city-of-hope-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/clinica-universidad-de-navarra-universidad-de-navarra/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/columbia-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/consorzio-oncotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/cspc-zhongqi-pharmaceutical-technology-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/daiichi-sankyo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dana-farber-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dartmouth-hitchcock-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/deepa-jagadeesh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/diwakar-davar/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dongguan-people-s-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dualitybio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/duke-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/dynavax-technologies-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eastern-cooperative-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eisai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eisbach-bio-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/eli-lilly-and-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/elpiscience-biopharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/emd-serono/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/emd-serono-research-development-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/emory-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/epizyme/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/essen-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/european-institute-of-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/european-lung-cancer-working-party/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/european-organisation-for-research-and-treatment-of-cancer-eortc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ever-supreme-bio-technology-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/federal-research-institute-of-pediatric-hematology-oncology-and-immunology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/federation-francophone-de-cancerologie-digestive/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fiona-thistlethwaite/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/first-affiliated-hospital-of-wannan-medical-college/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/first-affiliated-hospital-of-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/flame-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fondazione-per-la-medicina-personalizzata/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/forward-pharmaceuticals-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fox-chase-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fred-hutchinson-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fudan-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fujifilm-pharmaceuticals-u-s-a/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/fundaci-n-de-investigaci-n-hm/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/futurechem/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gabriel-tinoco/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/garden-state-cancer-center-at-the-center-for-molecular-medicine-and-immunology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gbg-forschungs-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genequantum-healthcare-suzhou-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genmab/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genta-incorporated/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/genzyme-a-sanofi-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/georgetown-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gilead-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/giselle-sholler/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/glaxosmithkline/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gog-foundation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gregory-daniels/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/groupe-oncologie-radiotherapie-tete-et-cou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/grupo-espa-ol-de-linfomas-y-transplante-aut-logo-de-m-dula-sea/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/grupo-espa-ol-de-tratamiento-de-tumores-de-cabeza-y-cuello/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/grupo-espanol-de-investigacion-en-sarcomas/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/guangdong-association-of-clinical-trials/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/guru-sonpavde/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/gustave-roussy-cancer-campus-grand-paris/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/h-lee-moffitt-cancer-center-and-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hadassah-medical-organization/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hallym-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hamilton-health-sciences-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hansoh-biomedical-r-d-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/heinrich-elinzano-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/helix-biopharma-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/helsinn-healthcare-sa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/helsinn-therapeutics-u-s/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/henan-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/herbert-irving-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hinova-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hoffmann-la-roche/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hospital-de-clinicas-de-porto-alegre/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/housey-healthcare-ulc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/huashan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/huazhong-university-of-science-and-technology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/huikai-li/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hull-university-teaching-hospitals-nhs-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hummingbird-bioscience/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hunan-province-tumor-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/hutchmed/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/icahn-school-of-medicine-at-mount-sinai/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ideaya-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/imcheck-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/immix-biopharma-australia-pty/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/immunitybio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/immunogen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/immunogenesis/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/indaptus-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/innolake-biopharm/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/innovent-biologics-suzhou-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/inova-health-care-services/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institut-curie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institut-f-r-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institute-of-hematology-blood-diseases-hospital-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/institute-of-oncology-ljubljana/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/instituto-de-investigaci-n-sanitaria-arag-n/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/intra-immusg-pte/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/inxmed-shanghai-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ionis-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ipsen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/irccs-san-raffaele/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/istituto-romagnolo-per-lo-studio-dei-tumori-dino-amadori-irst-s-r-l-irccs/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/janssen-research-development/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jason-j-luke-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jennifer-crombie-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiangmen-central-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiangsu-hengrui-medicine-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiangsu-simcere-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jiyan-liu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/john-hays/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/johns-hopkins-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jonsson-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/jun-guo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/juno-therapeutics-a-subsidiary-of-celgene/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/kadmon-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/klus-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/kyrre-eeg-emblem/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lei-liu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/leo-w-jenkins-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lepu-biopharma-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ligachem-biosciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/linnaeus-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/lymphoma-study-association/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/m-d-anderson-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mabwell-shanghai-bioscience-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/macrogenics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/masonic-cancer-center-university-of-minnesota/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/massachusetts-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mayo-clinic/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mbrace-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mediar-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medical-college-of-wisconsin/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medilink-therapeutics-suzhou-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medimmune/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/medsir/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/memorial-sloan-kettering-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/merck-sharp-dohme/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mersana-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/merus-b-v/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/michael-morse-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/millennium-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/minghui-pharmaceutical-hangzhou/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/mirati-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/modernatx/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/molecular-insight-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/montefiore-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/multitude-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nantcell/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nantes-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-cancer-institute-nci/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-guard-health-affairs/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-health-research-institutes-taiwan/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-heart-lung-and-blood-institute-nhlbi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-institute-of-allergy-and-infectious-diseases-niaid/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-institutes-of-health-clinical-center-cc/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/national-university-hospital-singapore/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nec-bio-b-v/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/neoimmunetech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/neurobiogen-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/neurological-surgery-p-c/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/newlink-genetics-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nextcure/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nordic-society-of-gynaecological-oncology-clinical-trials-unit/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/northwestern-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/novartis-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/novatim-immune-therapeutics-zhejiang-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/novelwise-pharmaceutical-corporation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nsabp-foundation/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/nurix-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/obi-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ohio-state-university-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ohsu-knight-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/omega-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oncoimmune-a-subsidiary-of-merck-co-rahway-new-jersey-usa/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oncolytics-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/onconano-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oncozyme-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oncxerna-theraputics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ono-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/orion-corporation-orion-pharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/oslo-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pdl-biopharma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-union-medical-college/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-union-medical-college-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peking-university-cancer-hospital-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/peter-kozuch/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pfizer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pharmamar/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/piramal-enterprises-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/polaris-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/prescient-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/prima-biomed/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/pusan-national-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/qilu-hospital-of-shandong-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/qilu-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/quantum-immunologics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rachel-miller/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/radboud-university-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/radiation-therapy-oncology-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rapa-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rapt-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/redhill-biopharma-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/regeneron-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/regina-elena-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/remegen-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/remix-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/repertoire-immune-medicines/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rockefeller-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/royal-marsden-nhs-foundation-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/ruijin-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/rutgers-the-state-university-of-new-jersey/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/samsung-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sangart/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sawa-ito-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/seagen-a-wholly-owned-subsidiary-of-pfizer/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/second-affiliated-hospital-school-of-medicine-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/seoul-national-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shandong-cancer-hospital-and-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shandong-tumor-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-6th-people-s-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-abelzeta/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-cancer-hospital-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-changzheng-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-chest-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-chia-tai-tianqing-pharmaceutical-technology-development-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-hengrui-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-henlius-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-jiao-tong-university-school-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-jmt-bio/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-junshi-bioscience-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-kanda-biotechnology-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-miracogen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-pulmonary-hospital-shanghai-china/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-yingli-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shanghai-zhongshan-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/shin-mineishi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sichuan-baili-pharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sichuan-kelun-biotech-biopharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sichuan-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sierra-oncology-a-gsk-company/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sir-run-run-shaw-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sixth-affiliated-hospital-sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sorrento-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/spanish-breast-cancer-research-group/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/spanish-cooperative-group-for-the-treatment-of-digestive-tumours-ttd/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/spectrum-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-george-s-university-of-london/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-joseph-s-hospital-and-medical-center-phoenix/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-jude-children-s-research-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/st-justine-s-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/stanford-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sterna-biologicals-gmbh-co-kg/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sumitomo-pharma-america/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sun-yat-sen-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sung-yong-lee/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/sunho-china-biopharmaceutical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/susanne-crocamo/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/suzhou-zelgen-biopharmaceuticals-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/swedish-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/swiss-cancer-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/swog-cancer-research-network/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/syndax-pharmaceuticals/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/synergene-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/taizhou-hanzhong-biomedical-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/takeda/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tang-du-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/teclison/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tersera-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tg-therapeutics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-clatterbridge-cancer-centre-nhs-foundation-trust/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-cleveland-clinic/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-first-affiliated-hospital-with-nanjing-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/the-methodist-hospital-research-institute/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/theraop/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/thevax-genetics-vaccine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/third-military-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tianjin-chest-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tianjin-medical-university-cancer-institute-and-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tianjin-medical-university-second-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/timmune-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/timothy-showalter-md/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tj-biopharma-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/translational-research-in-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/triumvira-immunologics/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tubulis-gmbh/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/tyk-medicines/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/unc-lineberger-comprehensive-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/union-hospital-tongji-medical-college-huazhong-university-of-science-and-technology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/universitaire-ziekenhuizen-ku-leuven/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-health-network-toronto/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-hospital-erlangen/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-hospital-freiburg/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-hospital-of-crete/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-alabama-at-birmingham/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-arizona/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-davis/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-irvine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-los-angeles/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-california-san-francisco/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-chicago/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-chile/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-colorado-denver/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-florida/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-kansas-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-massachusetts-worcester/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-miami/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-michigan-rogel-cancer-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-minnesota/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-oklahoma/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-rochester/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-sao-paulo-general-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-southampton/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-southern-california/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-texas-southwestern-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-turin-italy/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-utah/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-vermont-medical-center/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-washington/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/university-of-wisconsin-madison/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/vaccinex/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/vall-d-hebron-institute-of-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/veeda-oncology/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/vejle-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/vibrant-sciences-limited/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/vilnius-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/virginia-commonwealth-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/wake-forest-university-health-sciences/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/washington-university-school-of-medicine/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/weill-medical-college-of-cornell-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/west-china-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/wigen-biomedicine-technology-shanghai-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/women-s-hospital-school-of-medicine-zhejiang-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xencor/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xi-junjie/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xie-congying/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xin-hua-xu/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/xuzhou-medical-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yale-university/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/yu-jiren/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zealand-university-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhang-yi/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhejiang-cancer-hospital/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhejiang-genfleet-therapeutics-co/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhijie-wang/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zhimin-shao/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/sponsors/zsky-biotech/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05970627/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05913427/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04316442/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03228186/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01492673/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01952769/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01834183/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06370754/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05578222/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00612222/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00303251/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01354951/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00106002/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01563302/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00337545/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01893372/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00062101/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00019812/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00740181/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01264328/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03452228/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05005728/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00136565/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04116073/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06715241/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03631641/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05688605/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02928029/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03796429/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01017653/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00200395/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01267695/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07066995/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003957/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00604175/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003657/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00755157/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07218601/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00459901/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00312819/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06888830/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04787328/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04506567/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03610100/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02575300/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00072527/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06043427/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02971761/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01711242/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03891173/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03391973/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01677741/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00952029/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06965829/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02188745/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00980395/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02797977/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07117877/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05130177/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00086801/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00266812/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03321981/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03991130/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02947061/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04278222/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06529731/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06854445/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07022301/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003312/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03371381/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02774681/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02871219/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00200161/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003961/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06575686/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01230970/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03517969/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06528769/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04305054/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00634205/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02340156/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07050056/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01549951/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07637851/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05328102/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04524702/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05760053/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01472653/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06178445/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06052839/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04452877/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04121975/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00049101/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03013101/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00420381/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02576561/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03781869/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01871441/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00057954/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00751205/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00098605/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00006456/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07663422/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00015951/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03153202/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00831545/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03167177/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00006377/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05687357/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04513301/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05104801/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00516412/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07274761/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03585686/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02605486/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06482086/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02177773/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02588651/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00238251/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04409002/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00143845/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00251472/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02836639/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06680739/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01500577/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00015886/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00099970/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00262873/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00983541/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00334594/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03185494/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02574637/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02448537/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00242502/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06173037/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04054245/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04961801/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04484142/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01370070/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02967770/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01380769/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03089554/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00388154/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00025194/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04894994/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05651022/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04361851/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07147231/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04591431/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01503502/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07277972/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04956042/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02507570/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06662669/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04750941/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05824494/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00584766/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06159166/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05413356/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04989322/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04591002/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07271602/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01774253/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07185945/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00867672/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07546929/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01034631/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00810953/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06747845/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03493945/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06730672/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00508872/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01991977/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003501/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00054301/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00353301/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01402401/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01130701/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05295212/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00558181/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03897881/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01368419/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05146219/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03488667/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05500092/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04179864/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00089609/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04280081/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00046800/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07221500/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06477692/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06992336/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03604692/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03143036/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00984464/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01003899/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04517214/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04610684/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02763384/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02669719/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01764607/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00610792/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00425334/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06255964/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00301964/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02414009/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04243499/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05975463/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05845814/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07605416/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00070304/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00936052/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06085638/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01008358/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03579875/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00006381/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01972919/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05509530/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00077428/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04245865/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07153965/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00275067/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03248492/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00119392/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00101036/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00024271/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05458544/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03119064/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01348009/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03368963/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05168163/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02616393/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01697293/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00263016/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03151304/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05578430/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05042128/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06704828/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05593328/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06739265/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04009967/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01159067/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04071236/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05667636/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00421811/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06947811/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01647971/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06083844/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07590934/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00005964/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01142232/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05307198/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00622193/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00004193/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01979393/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01471106/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07176312/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06064812/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06285019/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04738630/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06256328/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01528865/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00575965/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03259867/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03377400/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05556200/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02498600/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00983307/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03964792/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00574236/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01853644/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02099864/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04058964/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00308087/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00070187/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00362921/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00019552/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00657267/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04681911/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04761744/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00086099/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02027363/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00477087/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06066216/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07080216/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05383716/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04411706/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00002833/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03497533/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00643565/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03723967/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04580836/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06449209/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07618793/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03970616/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03579004/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06155084/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03348033/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00022633/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00062933/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00866333/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05181865/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02624492/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06314334/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03352934/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01358734/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04220632/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00085293/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02985021/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01874938/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04841538/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07388836/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02535364/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01104298/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03432598/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02644863/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02730416/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00582816/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01741116/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00409006/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01111604/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03000452/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06767007/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07568236/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03776864/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00768664/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02716116/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05213884/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003584/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01864538/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06868849/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05121038/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00705549/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07530549/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03298893/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07184021/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02272816/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06500884/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02246049/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02960555/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04472143/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00135135/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07434843/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06532799/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05012098/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00585221/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07554521/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00004084/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05723432/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05148533/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00321893/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05165849/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07645326/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06150885/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03665285/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06699498/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03783949/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01900652/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07405476/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00874614/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04402008/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06885034/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02935634/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06355609/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03188432/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02499952/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06141226/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04631744/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03044626/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06607692/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03834571/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01827384/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01565499/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00855452/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03790111/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03181100/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05180799/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02520063/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00098345/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00585377/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00725764/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03387111/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07680764/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02559687/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05529316/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00491075/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00810719/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01736800/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01100944/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00020475/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04843709/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03041181/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02568267/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07070700/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01283334/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02474199/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03587311/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07170293/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03204812/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00769067/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02491892/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00985192/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06526819/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03941730/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06475300/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00769600/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01362296/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05093322/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02187302/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05918445/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01023477/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02236000/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00521144/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05578872/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00892177/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00118157/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00924001/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00068419/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02605967/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06161441/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05982522/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02047253/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04418219/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04539600/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03659136/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07136181/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00795665/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02124707/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04701307/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00467077/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00075400/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04609566/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01321437/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03739801/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03795012/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01693419/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06251492/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00131911/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04965090/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03735680/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05722886/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03250273/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00191854/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00626106/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05991349/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02139358/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00993655/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04590326/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04934514/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04130516/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07563738/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07064876/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04655976/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03792724/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03262779/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06631079/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07293754/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02900560/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04613596/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07222969/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06118086/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02317991/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06168786/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02521870/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03083041/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03901573/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02766582/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01803503/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00022542/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00659360/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04815720/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03991962/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02499861/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01246986/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03803254/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00003269/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05408845/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02236195/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04072042/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06377722/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03890731/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02722369/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05893056/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00568451/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02014831/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02661542/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02273973/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03690869/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07323641/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03193437/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07645261/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07179783/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04704154/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00006929/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05275777/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02484339/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01775501/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00818441/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06358677/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05218148/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07213817/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03990961/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00939770/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00378573/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07003139/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03086369/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01858883/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06008366/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05497453/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04866862/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06660654/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07290088/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06543056/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03778229/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04146831/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00900562/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04106362/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07197827/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03785873/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04727151/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00679341/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00462852/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01534455/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01839916/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03022578/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07307443/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04325776/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04582864/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03965234/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00321932/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06682728/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02243007/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01252667/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05338619/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02137564/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02633098/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01369498/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00559377/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03312530/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03016871/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02414269/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01838369/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03957902/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01357395/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05016544/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01868386/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00904839/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00904345/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02129439/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01919229/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01100528/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04211012/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05833919/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04655157/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02273362/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07452146/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04068103/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00505661/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00933387/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00828984/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04709276/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02479698/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07245797/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03149679/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00515086/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00369174/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03820596/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01077986/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01750073/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02155920/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02243579/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06710288/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02085070/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00182702/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00791037/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03325166/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01527045/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04937673/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06856837/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02177695/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03960541/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00058305/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00098631/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03982537/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01729845/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04401995/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06102057/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00083122/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07323056/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00383851/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04685070/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00087386/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07359053/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01851941/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02581137/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04775862/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01637961/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06317662/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07483983/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06207656/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05158062/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02561273/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03906669/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00899054/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05775146/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04208646/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05955105/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02599324/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02012088/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01267344/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00758134/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04595747/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00720304/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05993858/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01374425/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03304080/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00385580/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01728818/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00391118/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06172127/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02965378/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06498648/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00074308/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04453384/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01218048/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01795976/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01108458/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00243035/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00954135/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03087708/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00005940/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07622940/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05453825/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06708455/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00972335/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02562625/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00226239/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06320301/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04587830/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05518903/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01118351/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06029270/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06967805/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00939627/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00365053/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05588388/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04555837/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00337077/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01316757/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07172412/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01105377/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00966875/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04006119/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02757326/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01907815/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04599140/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03382340/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05323890/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02280785/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02086591/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03947385/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03940235/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01522976/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06254911/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03447678/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00043043/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02045017/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06142617/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04300140/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01163084/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03326947/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00559507/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06050707/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04554771/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01935947/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02134925/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00022698/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03404193/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00813943/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07583550/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05773820/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01076543/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03531918/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04785820/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01193868/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04957615/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06778408/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00042991/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06237920/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01606124/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02452008/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06395090/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04754425/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00004918/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07216560/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03664024/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00544908/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03574818/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05675813/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04065282/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03475628/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03558087/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01147016/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05435339/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02144675/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00466687/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00039377/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01145209/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02132598/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03394287/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01978236/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04416516/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06986057/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02867592/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01270321/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01518465/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05397171/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02452463/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04006821/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07275216/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03942328/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07343453/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04073602/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07439094/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07479485/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06086704/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05601401/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03384940/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07665190/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07087860/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07192120/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06782334/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01530698/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07459998/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06928363/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00929019/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07419867/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03319628/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00345293/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07307053/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07152782/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05714839/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06377566/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06962865/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06000033/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05714306/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03698552/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01648348/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00027599/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03007030/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07301229/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07527806/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06780098/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01846871/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07474064/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01567202/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01472146/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04838548/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04479267/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06957561/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04523688/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07150091/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05141747/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04242459/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06857279/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00753220/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05594095/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07590531/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05911958/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07459738/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04329429/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06587425/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00334776/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06655818/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06718933/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00313235/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06959108/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06003231/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04829604/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04132960/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04676360/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06155396/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07518979/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07649980/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03809013/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02744612/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06152367/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03544281/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02227199/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07472647/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00088985/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03359954/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07232602/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03656042/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01348256/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04745949/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05887609/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07368543/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05980481/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00868114/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03712202/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05672251/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06551051/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06919939/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07592767/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07329322/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05749588/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01492088/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07106762/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01635283/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07365280/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01926639/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06926998/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06547736/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06483334/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07460375/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01771107/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04152499/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04742153/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00852007/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01421667/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02828124/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06953089/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06864169/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03400917/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03729596/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02772094/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00103142/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05824325/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05830123/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05263869/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04965519/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03057795/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07428044/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06572319/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05941507/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01204684/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01734564/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06769152/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06219941/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06188559/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07630103/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03035331/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00776295/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00074230/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05126719/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06014190/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01146262/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04638582/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05943379/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07662863/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06509997/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07667335/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02262325/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06496490/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06788964/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06742892/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07102004/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04311034/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07514533/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01631552/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07367516/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00879489/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01111461/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06008379/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01153113/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02758717/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06431490/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04802759/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03610360/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07401537/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06106945/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05535244/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07229599/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07019337/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06242691/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07501169/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07672782/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06144723/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06328387/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07488676/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07150104/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07630974/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01393717/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07612787/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07077564/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05141786/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06649331/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01534078/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01856933/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07294508/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03606174/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05308225/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07193160/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03425279/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06198751/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05865990/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02310971/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01805037/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06780085/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05518032/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05652855/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07408063/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06145308/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07296809/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06793332/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04126200/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06848699/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05333809/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07375316/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07677475/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06525298/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07394244/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04699461/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07509515/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05445908/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06533826/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07419880/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06484361/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06480136/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06038396/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05631262/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01782742/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05460273/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07405151/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04032626/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02933255/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03339843/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06676917/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03604991/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03504488/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02504229/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03589469/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04838964/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07403136/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07145255/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06797999/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04940325/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06710132/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03786081/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07643103/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04300556/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06839066/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06224673/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03556345/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03668730/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07618923/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07531979/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04887870/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06007729/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07027072/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00902577/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07514975/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06303505/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06395103/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04839510/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06956690/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05296070/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01476410/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03500380/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05320588/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07084896/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07061639/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04879329/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05565807/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05338957/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04965766/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07490119/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07416253/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06865677/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07294534/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06464055/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07307287/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03233347/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05673785/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07181161/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04115761/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03505710/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04995419/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06452706/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06545617/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05320380/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01780662/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06823427/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07459751/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05613088/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05403242/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02880943/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07542717/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05582499/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05417230/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07126665/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07201675/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01973322/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT02606305/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06160609/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07529808/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04225767/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06305767/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04606914/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04084366/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07453394/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05797168/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07466303/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00499083/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07507526/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06822543/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07548060/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06843447/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03602079/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT01068353/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05041972/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06052423/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03951142/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT00006113/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07281209/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT04587687/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05190705/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT05800366/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT06657222/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT07564466/ 2026-07-02T20:00:17.216Z monthly 0.5 https://treelip.com/tools/clinical-program-risk-radar/oncology-phase-2-smidcap/trials/NCT03684694/ 2026-07-02T20:00:17.216Z monthly 0.5